Tag Archives: Ventolin

GSK Initiates Phase III Trials for Low Carbon Inhaler to Drastically Cut Emissions

(IN BRIEF) GSK, a leading pharmaceutical company, has unveiled plans to conduct Phase III trials in 2024 for a low carbon version of its popular inhaler, Ventolin (salbutamol). The initiative aims to reduce greenhouse gas emissions associated with the inhaler’s … Read the full press release